Clinical Research Directory
Browse clinical research sites, groups, and studies.
Personalized Therapies in Inflammatory Complex Disease
Sponsor: Assistance Publique - Hôpitaux de Paris
Summary
Inflammatory diseases may display atypical features making such patients impossible to classify. Management of these cases in daily practice cannot rely on the results of clinical trials nor on guidelines. DNA and RNA mapping have become major tools to understand and sometimes direct the treatment strategy in oncology. This study aims to test whether a precise analysis of molecular pathways in inflammatory, non classified diseases, can constitute a predictive tool of therapeutic efficiency
Official title: Personalized Targeted Therapies in Inflammatory Complex Multi Organ Disease
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
32
Start Date
2020-10-20
Completion Date
2025-11
Last Updated
2025-11-20
Healthy Volunteers
No
Conditions
Interventions
Kineret
100 mg, once/day sc 6 months
Humira
40 mg/15 days sc 6 months
Stelara
45 mg/12 weeks sc, 6 months
Cosentyx
300mg sc every week for 1 month, then 300 mg/month sc for 5 months
Roactemra
480 mg/perf/4 weeks 6 months
Rituximab
2 sessions of 1000 mg at inclusion and 15 days after inclusion
Locations (1)
Hôpital Cochin
Paris, France